| 证券代码：603716 | 证券简称：塞力医疗 | 公告编号：2025-070 | | --- | --- | --- | | 债券代码：113601 | 债券简称：塞力转债 | | 塞力斯医疗科技集团股份有限公司 关于实际控制人部分股份解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 塞力斯医疗科技集团股份有限公司（以下简称"公司"）控股股东赛海 （上海）健康科技有限公司（以下简称"赛海科技"）持有公司 21,642,540 股 无限售条件流通股股票，占公司总股本的 11.33%（截至 2025 年 6 月 30 日总股 本，下同）。赛海科技累计质押公司股份 14,000,000 股，占其持有公司股份比 例为 64.69%，占公司总股本比例为 7.33%。 公司实际控制人温伟先生持有公司股份 9,634,208 股，占公司总股本比 例为 5.04%。近日，温伟先生将其中 3,000,000 股股份办理完成了解除质押登记 手续，本次解除质押手续办理完毕后，温伟先生累计质押公司股份 5,300,000 股，占其 ...

证券之星消息，8月12日医药商业板块较上一交易日下跌0.28%，塞力医疗领跌。当日上证指数报收于 3665.92，上涨0.5%。深证成指报收于11351.63，上涨0.53%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 301015 | 百洋医药 | 26.39 | 4.31% | 13.85万 | | 3.60亿 | | 301408 | 华人健康 | 15.38 | 0.72% | 19.09万 | | 2.94亿 | | 002788 | 醫症医药 | 8.76 | 0.46% | 7.10万 | | 6226.18万 | | 000078 | 海王生物 | 2.73 | 0.37% | 54.67万 | | 1.51亿 | | 603368 | 柳药集团 | 18.35 | 0.22% | 8.06万 | | 1.48亿 | | 600713 | 南京医药 | 5.27 | 0.19% | 10.26万 | | 5411.55万 | | ...

Group 1 - The SPD concept is gaining traction in the secondary market, with companies like Seli Medical, Guoke Hengtai, and Chongyao Holdings seeing significant stock price increases [1] - SPD stands for Supply, Processing, and Distribution, representing a modern supply chain management model in healthcare [1] - SPD business involves operators signing contracts with medical institutions to centralize the supply, inventory, processing, and distribution of medical materials [1] Group 2 - The SPD model allows companies to build smart supply chain management platforms for medical institutions, providing diversified services to enhance operational efficiency [1] - The introduction of lean management in SPD can reduce waste, optimize processes, and lower procurement costs for medical institutions [1] - The analyst predicts a substantial market demand for SPD in Chinese hospitals due to the rising costs of medical supplies, which account for 50% to 55% of hospital expenses [2] Group 3 - Companies are actively responding to the growing interest in SPD and hospital information technology on investor platforms [2] - Seli Medical claims a significant market share in SPD projects and aims to expand through regional cooperation [2] - Chongyao Holdings has implemented around 80 SPD projects across 14 provinces, serving nearly 70 medical institutions [2]

Company Overview - As of August 8, 2025, the stock price of Sely Medical is reported at 27.60 yuan, reflecting an increase of 0.73% from the previous trading day [1] - The company operates in the pharmaceutical commercial sector, focusing on medical testing centralized services and the research, production, and sales of in vitro diagnostic products [1] - Sely Medical's product range includes biochemistry, immunology, and molecular diagnostics, with business operations extending across multiple regions, including Hubei [1] Stock Performance - During the trading session on August 8, Sely Medical's stock exhibited significant volatility, with a morning rebound at 9:35 AM leading to a rise of over 2% within five minutes, followed by a quick pullback at 9:44 AM with a drop exceeding 2% [1] - The stock's opening price was 27.11 yuan, reaching a high of 28.40 yuan and a low of 26.20 yuan, resulting in a trading range of 8.03% [1] - The total trading volume for the day amounted to 9.85 billion yuan [1] Capital Flow - On August 8, the net inflow of main funds was 33.17 million yuan, accounting for 0.63% of the circulating market value [1] - However, over the past five trading days, the overall trend for main funds has shown a net outflow of 456 million yuan, which represents 8.65% of the circulating market value [1]

Core Insights - The precision medicine sector experienced a slight increase of 0.62% on August 7, with a net outflow of main capital amounting to 93.50 million yuan [1] - A total of 23 stocks within the sector saw gains, while another 23 stocks faced declines [1] Capital Flow Analysis - The companies with the highest net outflows were: - Qianhong Pharmaceutical: 187 million yuan - Saily Medical: 139 million yuan - Zhifei Biological: 134 million yuan - Betta Pharmaceuticals: 104 million yuan - Junshi Biosciences-U: 78.25 million yuan [1] Notable Stock Performances - The following companies showed significant net inflows: - Berry Genomics: 207 million yuan, with a price increase of 5.26% - Lide Man: 158 million yuan, with a price increase of 20.02% - Kehua Bio: 143 million yuan, with a price increase of 9.96% - Da'an Gene: 60.09 million yuan, with a price increase of 2.98% - Sanbo Brain Science: 57.30 million yuan, with a price increase of 5.12% [1]

Company Overview - Sely Medical's stock price showed volatility on August 7, closing at 27.40 yuan, down 2.32% from the previous trading day [1] - The opening price was 27.77 yuan, with a high of 29.32 yuan and a low of 27.22 yuan, resulting in an intraday fluctuation of 7.49% [1] - The company operates in the pharmaceutical commercial sector, focusing on the research, production, and sales of medical devices, including in vitro diagnostic reagents and medical equipment [1] Financial Performance - On August 7, the net outflow of main funds was 139 million yuan, accounting for 2.66% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow reached 465 million yuan, representing 8.89% of the circulating market value [1] - The trading volume for the day was 443,300 hands, with a total transaction amount of 1.247 billion yuan [1]

Core Insights - The DRG/DIP concept increased by 1.00%, ranking 10th among concept sectors, with 11 stocks rising, including Jiarun Technology which hit a 20% limit up [1] - Major gainers in the sector included Jiahe Meikang, Wanda Information, and Taiji Co., with respective increases of 3.68%, 3.08%, and 2.98% [1] - The sector experienced a net outflow of 229 million yuan, with 10 stocks seeing net inflows, and Wanda Information leading with a net inflow of 65.92 million yuan [2][3] Sector Performance - The top-performing concept sectors included Rare Earth Permanent Magnet (+3.24%), Brain-Computer Interface (+2.69%), and Hyperbaric Oxygen Chamber (+2.56%), while the weight-loss drug sector saw a decline of -1.70% [2] - The DRG/DIP concept had a net inflow ratio led by Wanda Information at 10.09%, followed by ST Yilianzhong at 5.78% and Taiji Co. at 4.82% [3][4] Stock Specifics - Key stocks in the DRG/DIP concept included: - Wanda Information: +3.08%, net inflow of 65.92 million yuan, turnover rate of 5.34% [3] - Weining Health: +1.72%, net inflow of 62.81 million yuan, turnover rate of 6.37% [3] - Taiji Co.: +2.98%, net inflow of 42.14 million yuan, turnover rate of 5.36% [3] - Notable declines were seen in stocks like Maidi Technology (-2.61%) and Seli Medical (-2.32%), with significant net outflows [4]

截至2025年8月6日收盘，塞力医疗股价报28.05元，较前一交易日下跌1.45元，跌幅4.92%。当日开盘价 为29.85元，最高触及30.29元，最低下探至27.90元，成交量为38.61万手，成交额达10.99亿元。 塞力医疗属于医药商业板块，公司主营业务涵盖医疗器械、体外诊断产品的研发、生产和销售，同时提 供医疗供应链管理服务。其业务范围涉及医院集约化运营、区域检验中心建设等领域。 8月6日早盘，塞力医疗股价快速回调，5分钟内跌幅超过2%，盘中最低报29.21元。当日主力资金净流 出1.65亿元，近五个交易日累计净流出4.02亿元。 风险提示：股市有风险，投资需谨慎。 来源:金融界 ...

Core Viewpoint - The stock price of Saily Medical closed at 29.50 yuan on August 5, showing a decline of 0.51% compared to the previous trading day, with notable price fluctuations throughout the day [1] Company Overview - Saily Medical's main business includes centralized marketing and service for medical testing, as well as the agency, research, production, and sales of in vitro diagnostic products [1] - The company holds a significant market influence in the medical commercial sector within Hubei province [1] Market Activity - On August 5, the net outflow of main funds was 4.6852 million yuan, with a cumulative net outflow of 276 million yuan over the past five trading days [1] - The trading volume for the day reached 1.055 billion yuan, with a turnover rate of 18.99%, indicating a high level of market activity [1]

证券之星消息，8月4日医药商业板块较上一交易日下跌0.23%，塞力医疗领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301015 | 目洋医药 | 22.39 | 1.91% | 12.41万 | 2.71亿 | | 603939 | 益丰药房 | 24.60 | 1.61% | 6.75万 | 1.65亿 | | 603233 | 大参林 | 17.58 | 0.92% | 4.67万 | 8141.04万 | | 600511 | 国药股份 | 30.04 | 0.74% | 5.65万 | 1.69亿 | | 603122 | 合富中国 | 7.28 | 0.55% | 6.14万 | 4434.06万 | | 301017 | 漱玉平民 | 13.35 | 0.45% | 6.99万 | 9203.55万 | | 605266 | 健之佳 | 22.0 ...